25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward

Tuberculosis is second only to COVID-19 as a cause of death from a single infectious agent. In 2020, almost 10 million people were estimated to have developed tuberculosis and it caused 1·5 million deaths. Around a quarter of deaths caused by antimicrobial resistance are due to rifampicin-resistant...

Descripción completa

Detalles Bibliográficos
Autores principales: Dean, Anna S, Tosas Auguet, Olga, Glaziou, Philippe, Zignol, Matteo, Ismail, Nazir, Kasaeva, Tereza, Floyd, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Health Organization. Published by Elsevier Ltd. 2022
Materias:
Personal View
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893725/
https://www.ncbi.nlm.nih.gov/pubmed/35248168
http://dx.doi.org/10.1016/S1473-3099(21)00808-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893725/
https://www.ncbi.nlm.nih.gov/pubmed/35248168
http://dx.doi.org/10.1016/S1473-3099(21)00808-2

Ejemplares similares